Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Dyne Therapeutics Inc (NASDAQ: DYN) was $31.50 for the day, up 1.81% from the previous closing price of $30.94. In other words, the price has increased by $1.81 from its previous closing price. On the day, 1.04 million shares were traded. DYN stock price reached its highest trading level at $31.56 during the session, while it also had its lowest trading level at $29.76.
Ratios:
Our analysis of DYN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.83 and its Current Ratio is at 21.83. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 21, 2024, Reiterated its Buy rating but revised its target price to $42 from $31 previously.
On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.
On February 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.H.C. Wainwright initiated its Buy rating on February 20, 2024, with a $36 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 20 ’24 when Beskrovnaya Oxana sold 30,426 shares for $32.96 per share. The transaction valued at 1,002,751 led to the insider holds 149,647 shares of the business.
McNeill Jonathan sold 2,774 shares of DYN for $78,420 on May 16 ’24. The Chief Business Officer now owns 136,634 shares after completing the transaction at $28.27 per share. On May 16 ’24, another insider, HIGH SUSANNA GATTI, who serves as the Chief Operating Officer of the company, sold 2,738 shares for $28.27 each. As a result, the insider received 77,402 and left with 154,062 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 3132914432 and an Enterprise Value of 2325623040.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $35.98, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 13.28%, while the 200-Day Moving Average is calculated to be 73.22%.
Shares Statistics:
DYN traded an average of 1.32M shares per day over the past three months and 1229560 shares per day over the past ten days. A total of 97.88M shares are outstanding, with a floating share count of 64.30M. Insiders hold about 34.31% of the company’s shares, while institutions hold 68.39% stake in the company. Shares short for DYN as of 1715731200 were 9355677 with a Short Ratio of 7.10, compared to 1713139200 on 9023636. Therefore, it implies a Short% of Shares Outstanding of 9355677 and a Short% of Float of 13.120000000000001.
